missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocilizumab Recombinant Human Monoclonal Antibody (rhPM-1 (Tocilizumab)), Invitrogen™
Human Recombinant Monoclonal Antibody
Brand: Invitrogen MA548061
This item is not returnable.
View return policy
Description
Specificity: Tocilizumab binds specifically to both the membrane bound and soluble forms of human IL-6R. The IL6 receptor is a protein complex consisting of an IL-6 receptor subunit (IL6R) and interleukin 6 signal transducer Glycoprotein 130. Interleukin 6 (IL6) is a potent pleiotropic cytokine that regulates cell growth and differentiation and plays an important role in immune response.
Tocilizumab (Actemra) is a humanized monoclonal antibody that is developed by Hoffmann-La Roche and Chugai for the treatment of patients with rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. Tocilizumab binds to the interleukin-6 receptor (IL-6R) and blocks its interaction with interleukin 6 (IL-6), hindering IL-6 from exerting its pro-inflammatory effects.
Specifications
| Tocilizumab | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 0.02% ProClin 300 | |
| Human | |
| Affinity chromatography | |
| RUO | |
| Human | |
| Liquid |
| ELISA, Inhibition Assays | |
| rhPM-1 (Tocilizumab) | |
| Unconjugated | |
| IL-6R; Actemra; Atlizumab; MRA; R-1569; RHPM-1; RO-4877533 | |
| This antibody was prepared by CDR grafting of mouse AUK 12-20 antibody onto a human framework regions. | |
| 200 μg | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| IgG1 κ |